John Gribben

Default user avatar

Queen Mary, University of London
Barts & The London School of Medicine & Dentistry
Charterhouse Square
London
EC1M 6BQ
United Kingdom

Email: j.gribben@qmul.ac.uk
Tel: 020 7882 3804
Web: Lab website

Professor John Gribben is a doctor and researcher at Barts and the London Trust Cancer Centre. He and his team at the Barts Experimental Cancer Medicine Centre (ECMC) are developing and testing new ways to treat cancer.

More about John Gribben
Studies immune function in cancer patients with particular interest in the role of the immune microenvironment in lymphoma and leukaemia to improve immunotherapy approaches in cancer.
Full scientific summary…

John Gribben other research projects

Improvement of Treatment for Haematological Malignancy
Biological Sciences Committee (BSC) Programme Grants
Funding period: 01 April 2006 to 31 March 2012

Biological Sciences Committee (BSC) Programme Grants
Funding period: 01 April 2007 to 31 March 2012

Recent publications


Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy

Blood.2009;114 :4713-4720

Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts

Blood.2009;114 :3909-3916

More publications…